Sun, Apr 20, 2014, 5:34 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

truont2 2 posts  |  Last Activity: Apr 7, 2014 2:36 PM Member since: May 28, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Working Capital

    by gypsydoc Apr 7, 2014 10:23 AM
    truont2 truont2 Apr 7, 2014 2:36 PM Flag

    To be used toward Marvel and Mirror I hope...Why are they using money on clinicals for other indications vs finishing up their existing studies?

    Sentiment: Hold

  • Reply to

    Anyone else excited for the recent news?

    by brujo324 Nov 26, 2013 1:47 PM
    truont2 truont2 Feb 12, 2014 3:15 PM Flag

    I'm very impressed with this innovative and clever company. Relying on licensing for p-aat then using high efficacy recombinant aat (animal models - 40x lower dose) to treat those licensing patents in the future. The recombinant aat is not too novel for the approval process and can be supported with aat safety data - minimizing a lot of risk. I have no doubt that this company will be bought out early after a partnership agreement...effective diabetes 1/COPD/GVH therapy are too big to ignore with fc-aat potential. When fc-aat or its derivative is approved,traditional aat companies will need another inhibitor to compete. Management is also top notch with an excellent CEO and CSO.

    Sentiment: Buy

SIGA
2.79-0.01(-0.36%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST
Constellation Brands Inc.
NYSEThu, Apr 17, 2014 4:06 PM EDT